1. Home
  2. NREF vs CCCC Comparison

NREF vs CCCC Comparison

Compare NREF & CCCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NexPoint Real Estate Finance Inc.

NREF

NexPoint Real Estate Finance Inc.

HOLD

Current Price

$14.42

Market Cap

253.6M

Sector

Real Estate

ML Signal

HOLD

Logo C4 Therapeutics Inc.

CCCC

C4 Therapeutics Inc.

HOLD

Current Price

$2.03

Market Cap

240.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NREF
CCCC
Founded
2019
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
253.6M
240.3M
IPO Year
2020
2020

Fundamental Metrics

Financial Performance
Metric
NREF
CCCC
Price
$14.42
$2.03
Analyst Decision
Hold
Strong Buy
Analyst Count
3
5
Target Price
$14.75
$7.25
AVG Volume (30 Days)
64.6K
2.0M
Earning Date
10-30-2025
11-06-2025
Dividend Yield
14.07%
N/A
EPS Growth
132.43
N/A
EPS
3.08
N/A
Revenue
$151,560,000.00
$30,108,000.00
Revenue This Year
$23.96
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$4.62
N/A
Revenue Growth
107.15
N/A
52 Week Low
$12.14
$1.09
52 Week High
$16.80
$4.26

Technical Indicators

Market Signals
Indicator
NREF
CCCC
Relative Strength Index (RSI) 46.31 34.04
Support Level $14.25 $2.00
Resistance Level $14.64 $2.69
Average True Range (ATR) 0.26 0.18
MACD -0.08 -0.07
Stochastic Oscillator 0.93 3.55

Price Performance

Historical Comparison
NREF
CCCC

About NREF NexPoint Real Estate Finance Inc.

NexPoint Real Estate Finance Inc is a real estate investment trust. The company provides structured financing solutions by investing in mid-sized multifamily, storage and select-service, and extended-stay hospitality properties. Its investment objective is to generate attractive, risk-adjusted returns for stockholders over the long term. The Company is focused on originating, structuring and investing in first-lien mortgage loans, mezzanine loans, preferred equity, convertible notes, multifamily properties, and common equity investments, as well as multi-family and single-family rental ("SFR") commercial mortgage-backed securities securitizations ("CMBS securitizations"), multifamily structured credit risk notes ("MSCR Notes") and mortgage-backed securities.

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.

Share on Social Networks: